![Ryan Asay](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Career history of Ryan Asay
Former positions of Ryan Asay
Companies | Position | Start | End |
---|---|---|---|
MIRATI THERAPEUTICS | Corporate Officer/Principal | 01/04/2020 | 23/01/2024 |
SPARK THERAPEUTICS, INC. | Investor Relations Contact | 01/01/2017 | 01/02/2020 |
Statistics
International
United States | 3 |
Operational
Investor Relations Contact | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Spark Therapeutics, Inc.
![]() Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
Mirati Therapeutics, Inc.
![]() Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Ryan Asay
- Experience